Björn Walse

4PUBLICATIONS
17CO-AUTHORS
Medical devicesMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Sep 29, 2023
Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.

Ganna Petruk, Manoj Puthia, Firdaus Samsudin

|Apr 05, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity.

Mark F Maurer, Katherine E Lewis, Joseph L Kuijper

|Jun 22, 2018
Collagen VI Contains Multiple Host Defense Peptides with Potent In Vivo Activity.

Suado M Abdillahi, Tobias Maaß, Gopinath Kasetty

Pageof 1

Frequent Collaborators

3 joint publications

Artur Schmidtchen

2 joint publications

Simon Ekström

2 joint publications

Peter J Bond

2 joint publications

Sven Kjellström

2 joint publications

Snejana Hyllén

2 joint publications

Franziska Olm

2 joint publications

Jitka Petrlova

2 joint publications

Ganna Petruk

2 joint publications

Manoj Puthia

1 joint publications

Mark W Rixon

Frequent Collaborators

3 joint publications

Artur Schmidtchen

2 joint publications

Simon Ekström

2 joint publications

Peter J Bond

2 joint publications

Sven Kjellström

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on : Jul 26, 2017

12.4K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.6K
See more related videos

Top Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on : Jul 26, 2017

12.4K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.6K
See more related videos